Form 8-K - Current report:
SEC Accession No. 0001558370-21-005478
Filing Date
2021-05-03
Accepted
2021-05-03 09:00:34
Documents
14
Period of Report
2021-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K glyc-20210503x8k.htm   iXBRL 8-K 44271
2 EX-99.1 glyc-20210503xex99d1.htm EX-99.1 116547
3 GRAPHIC glyc-20210503xex99d1001.jpg GRAPHIC 7194
  Complete submission text file 0001558370-21-005478.txt   301271

Data Files

Seq Description Document Type Size
4 EX-101.SCH glyc-20210503.xsd EX-101.SCH 3222
5 EX-101.LAB glyc-20210503_lab.xml EX-101.LAB 15497
6 EX-101.PRE glyc-20210503_pre.xml EX-101.PRE 10516
7 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20210503x8k_htm.xml XML 4618
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 21881607
SIC: 2834 Pharmaceutical Preparations